Timing and Dose Regimens of Marrow Mesenchymal Stem Cell Transplantation Affect the Outcomes and Neuroinflammatory Response After Ischemic Stroke

CNS Neuroscience and Therapeutics

Volumn 20, Issue 4, 2014, Pages 317-326

  Wang, Liu Qing ^a   Lin, Zhen Zhen ^a   Zhang, Hong Xia ^a   Shao, Bei ^a   Xiao, Li ^a   Jiang, Hui Gang ^a   Zhuge, Qi Chuan ^a   Xie, Luo Kun ^b   Wang, Brian ^b   Su, Dong Ming ^a,b   Jin, Kun Lin ^a,b  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

Injury; Ischemia; Marrow mesenchymal stem cells; Neuroinflammation; Stroke; Transplantation

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW TRANSPLANTATION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CELL COUNT; CONTROLLED STUDY; EXPERIMENTAL BEHAVIORAL TEST; FUNCTIONAL STATUS; GAMMA DELTA T LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; LYMPHOCYTE COUNT; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MICROGLIA; MIDDLE CEREBRAL ARTERY OCCLUSION; MOTOR DYSFUNCTION; NERVE CELL INHIBITION; NERVOUS SYSTEM INFLAMMATION; NEUROMODULATION; NONHUMAN; OUTCOME ASSESSMENT; RAT; REGULATORY T LYMPHOCYTE; TIME TO TREATMENT; TREATMENT RESPONSE; ADULT; ANIMAL; BRAIN; CELL CULTURE; CONVALESCENCE; DISEASE MODEL; IMMUNOLOGY; INFARCTION, MIDDLE CEREBRAL ARTERY; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PROCEDURES; SPRAGUE DAWLEY RAT; STROKE; SURGERY; T LYMPHOCYTE; TIME; TREATMENT OUTCOME;

ADULT; ANIMALS; BRAIN; BRAIN ISCHEMIA; CELLS, CULTURED; CYTOKINES; DISEASE MODELS, ANIMAL; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; MACROPHAGES; MESENCHYMAL STEM CELL TRANSPLANTATION; MICROGLIA; MIDDLE AGED; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; STROKE; T-LYMPHOCYTES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84896049668     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/cns.12216     Document Type: Article

References (43)

1. Kalladka D, Muir KW. Stem cell therapy in stroke: Designing clinical trials. Neurochem Int 2011;59:367-370.
2. Locatelli F, Bersano A, Ballabio E, et al. Stem cell therapy in stroke. Cell Mol Life Sci 2009;66:757-772.
3. Bersano A, Ballabio E, Lanfranconi S, et al. Clinical studies in stem cells transplantation for stroke: a review. Curr Vasc Pharmacol 2010;8:29-34.
4. Hicks A, Jolkkonen J. Challenges and possibilities of intravascular cell therapy in stroke. Acta Neurobiol Exp (Wars) 2009;69:1-11.
5. Guzman R, Choi R, Gera A, De Los Angeles A, Andres RH, Steinberg GK. Intravascular cell replacement therapy for stroke. Neurosurg Focus 2008;24:E15.
6. Bliss T, Guzman R, Daadi M, Steinberg GK. Cell transplantation therapy for stroke. Stroke 2007;38:817-826.
7. Parr AM, Tator CH, Keating A. Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury. Bone Marrow Transplant 2007;40:609-619.
8. Hokari M, Kuroda S, Shichinohe H, Yano S, Hida K, Iwasaki Y. Bone marrow stromal cells protect and repair damaged neurons through multiple mechanisms. J Neurosci Res 2008;86:1024-1035.
9. Prockop DJ, Gregory CA, Spees JL. One strategy for cell and gene therapy: Harnessing the power of adult stem cells to repair tissues. Proc Natl Acad Sci U S A 2003;100(Suppl 1):11917-11923.
10. Nawashiro H, Martin D, Hallenbeck JM. Inhibition of tumor necrosis factor and amelioration of brain infarction in mice. J Cereb Blood Flow Metab 1997;17:229-232.
11. Won SJ, Xie L, Kim SH, et al. Influence of age on the response to fibroblast growth factor-2 treatment in a rat model of stroke. Brain Res 2006;1123:237-244.
12. Swanson RA, Morton MT, Tsao-Wu G, Savalos RA, Davidson C, Sharp FR. A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab 1990;10:290-293.
13. Sun F, Xie L, Mao X, Hill J, Greenberg DA, Jin K. Effect of a contralateral lesion on neurological recovery from stroke in rats. Restor Neurol Neurosci 2012;30:491-495.
14. Jin K, Mao XO, Batteur S, Sun Y, Greenberg DA. Induction of neuronal markers in bone marrow cells: Differential effects of growth factors and patterns of intracellular expression. Exp Neurol 2003;184:78-89.
15. Shichita T, Sugiyama Y, Ooboshi H, et al. Pivotal role of cerebral interleukin-17-producing gammadelta T cells in the delayed phase of ischemic brain injury. Nat Med 2009;15:946-950.
16. Frenkel D, Huang Z, Maron R, Koldzic DN, Moskowitz MA, Weiner HL. Neuroprotection by IL-10-producing MOG CD4+ T cells following ischemic stroke. J Neurol Sci 2005;233:125-132.
17. Gonzalez RG. Imaging-guided acute ischemic stroke therapy: From "time is brain" to "physiology is brain". AJNR Am J Neuroradiol 2006;27:728-735.
18. Bliss TM, Andres RH, Steinberg GK. Optimizing the success of cell transplantation therapy for stroke. Neurobiol Dis 2010;37:275-283.
19. Darsalia V, Allison SJ, Cusulin C, et al. Cell number and timing of transplantation determine survival of human neural stem cell grafts in stroke-damaged rat brain. J Cereb Blood Flow Metab 2011;31:235-242.
20. Nishino H, Borlongan CV. Restoration of function by neural transplantation in the ischemic brain. Prog Brain Res 2000;127:461-476.
21. Arvidsson A, Collin T, Kirik D, Kokaia Z, Lindvall O. Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat Med 2002;8:963-970.
22. Jin K, Sun Y, Xie L, et al. Directed migration of neuronal precursors into the ischemic cerebral cortex and striatum. Mol Cell Neurosci 2003;24:171-189.
23. Savitz SI, Chopp M, Deans R, Carmichael ST, Phinney D, Wechsler L. Stem Cell Therapy as an Emerging Paradigm for Stroke (STEPS) II. Stroke 2011;42:825-829.
24. England T, Martin P, Bath PM. Stem cells for enhancing recovery after stroke: A review. Int J Stroke 2009;4:101-110.
25. Wei L, Fraser JL, Lu ZY, Hu X, Yu SP. Transplantation of hypoxia preconditioned bone marrow mesenchymal stem cells enhances angiogenesis and neurogenesis after cerebral ischemia in rats. Neurobiol Dis 2012;46:635-645.
26. Uccelli A, Laroni A, Freedman MS. Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases. Lancet Neurol 2011;10:649-656.
27. McGuckin CP, Jurga M, Miller AM, et al. Ischemic brain injury: A consortium analysis of key factors involved in mesenchymal stem cell-mediated inflammatory reduction. Arch Biochem Biophys 2013;534:88-97.
28. Yoo SW, Chang DY, Lee HS, et al. Immune following suppression mesenchymal stem cell transplantation in the ischemic brain is mediated by TGF-beta. Neurobiol Dis 2013;58:249-257.
29. Gelderblom M, Leypoldt F, Steinbach K, et al. Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke 2009;40:1849-1857.
30. Lee SC, Liu W, Dickson DW, Brosnan CF, Berman JW. Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1 beta. J Immunol 1993;150:2659-2667.
31. Moskowitz MA, Lo EH, Iadecola C. The science of stroke: Mechanisms in search of treatments. Neuron 2010;67:181-198.
32. Gu L, Xiong X, Zhang H, Xu B, Steinberg GK, Zhao H. Distinctive effects of T cell subsets in neuronal injury induced by cocultured splenocytes in vitro and by in vivo stroke in mice. Stroke 2012;43:1941-1946.
33. Planas AM, Chamorro A. Regulatory T cells protect the brain after stroke. Nat Med 2009;15:138-139.
34. Kleinschnitz C, Kraft P, Dreykluft A, et al. Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature. Blood 2012;121:679-691.
35. Ren X, Akiyoshi K, Vandenbark AA, Hurn PD, Offner H. CD4+FoxP3+ regulatory T-cells in cerebral ischemic stroke. Metab Brain Dis 2011;26:87-90.
36. Baruch K, Ron-Harel N, Gal H, et al. CNS-specific immunity at the choroid plexus shifts toward destructive Th2 inflammation in brain aging. Proc Natl Acad Sci USA 2013;110:2264-2269.
37. Liesz A, Suri-Payer E, Veltkamp C, et al. Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat Med 2009;15:192-199.
38. Le Blanc K, Mougiakakos D. Multipotent mesenchymal stromal cells and the innate immune system. Nat Rev Immunol 2012;12:383-396.
39. Prigione I, Benvenuto F, Bocca P, Battistini L, Uccelli A, Pistoia V. Reciprocal interactions between human mesenchymal stem cells and gammadelta T cells or invariant natural killer T cells. Stem Cells 2009;27:693-702.
40. Burr SP, Dazzi F, Garden OA. Mesenchymal stromal cells and regulatory T cells: The Yin and Yang of peripheral tolerance? Immunol Cell Biol 2013;91:12-18.
41. Tureyen K, Brooks N, Bowen K, Svaren J, Vemuganti R. Transcription factor early growth response-1 induction mediates inflammatory gene expression and brain damage following transient focal ischemia. J Neurochem 2008;105:1313-1324.
42. Lakhan SE, Kirchgessner A, Hofer M. Inflammatory mechanisms in ischemic stroke: Therapeutic approaches. J Transl Med 2009;7:97.
43. Strle K, Zhou JH, Shen WH, et al. Interleukin-10 in the brain. Crit Rev Immunol 2001;21:427-449.